ALCAM and non-small cell lung carcinoma: Subpopulation of nonsmall cell lung cancer (NSCLC) triple-positive for EPCAM, ALCAM, and CD44 possessed CSC characteristics, including being highly proliferative, having greater clonogenicity, ability for self-renewal through spheroid formation, and chemoresistance [33].